Fidson Healthcare Plc started operations on March 1, 1995 as a local distributor of pharmaceutical products. Barely a year after, the company moved into an importation of its own brand of finished medicines. The company set up its first local manufacturing facility in July 2002. In March 2005, Fidson became the first company in sub-Saharan Africa to manufacture Antiretroviral (ARVs) drugs.In February 2007, Fidson set up a second manufacturing facility and ceded the former manufacturing facility to an international joint venture project, which led to setting up of Ecomed Pharma Limited. 2006 they completed their 2nd manufacturing plant in Ota, Nigeria.in 2008 the company also completed their 3rd Factory (FPL)
In November of 2007, the company received the NIS ISO 9001:2000 certification of its Quality Management System by the Standard Organization of Nigeria (SON). In 2008, the company was listed on the floor of the Nigerian Stock Exchange, NSE to become a publicly quoted company. In 2009, the company won the Financial Standard Sector Leader Award and received the NIS ISO 9001:2008 Certification in 2011.
Fidson Healthcare Plc is a pharmaceutical manufacturing company in Nigeria. Ever since they have built and cultured an organizational framework that has steadily helped them gain ascendancy in the industry, they have crafted the pharmaceutical architecture of the industry over the years of their existence, playing very defining roles in the emergence of the new generation of industry players. Innovation, Excellence, Passion, Integrity and Ownership...are five core values that form the substructure on which they have built a world-class company that has earned the respect and admiration of even the fiercest of our competitors.
They currently run a CGMP compliant manufacturing facility and is one of a few Nigerian pharmaceutical manufacturers that are candidates for the WHO GMP certification. The company is into technical collaboration with various overseas manufacturers, most of whom are market leaders in their areas of specialization in order to deliver unique products and cost-effective services.
AWARDS
2015 - Pearl Awards; for Pharmaceutical Manufacturer of the Year.
2014 - Frost & Sullivan Growth, Innovation Excellence Awards; 4
2015 - BusinessDay Top 25 CEO Awards
2012 -Pearl Awards; for Most Outstanding CEO of the Year
2014 - Nigerian Healthcare Excellence Awards; (NHEA) 2014
2009 - Awarded FS sector leader award;
BOARD OF DIRECTORS
Mr. Segun Adebanji - Chairman
Mr Fidelis Ayebae - MD/CEO
Mrs Olufunmilola Ayebae - Non-Executive Director
Chief (Mrs.) A. P. Sadauki, OON - Non-Executive Director
Mr Emmanuel E. Imoagene- Non-Executive Director
Mr Olugbenga Olayeye - Sales & Marketing Director
Mr Biola Adebayo - Operations Director.
268, Ikorodu Road, Obanikoro P. O. Box 7210, Shomolu, Lagos, Nigeria
Phone: +234 (0) 8077008888, +234(1)3429102
Please login to give a review.
The Nigerian Exchange (NGX) closed in the red at the end of Friday's trading session. The All-Share Index (ASI) traded -0.01% down to close at ...
A dividend of 50 kobos per share has been approved by Fidson Healthcare Plc for its shareholders. The company approved this during its 23rd Ann...
The Nigerian stock market began trading for the week on Monday still on a negative mood with 0.27 per cent loss due to renewed profit-taking. Speci...
The Nigerian Stock Exchange (NSE) market closed with 5,486.00 deals on Thursday, March 4th, 2021, higher than the 4,714.00 deals on Wednesday, M...
FMDQ Securities Exchange Ltd has approved the registration of the Fidson Healthcare Plc N10 billion Commercial Paper (CP) pmme on its platform. The...
The Nigerian Stock Exchange (NSE) market closed with 4,567.00 deals on Thursday, February 25th, 2021, lower than the 5,470.00 deals on Wednesday, Febr...
The Nigerian Stock Exchange (NSE) market closed with 4,083.00 deals on Wednesday, February 17th, 2021, lower than the 5,040.00 deals on Tuesday, ...
The Nigerian Stock Exchange (NSE) market closed with 5,718.00 deals on Wednesday, February 10th, 2021, lower than the 4,969.00 deals on Monday, F...
The Nigerian Stock Exchange (NSE) market closed with 5,251.00 deals on Monday, February 8th, 2021, lower than the 5998.00 deals on Friday, February 5t...
The Nigerian Stock Exchange (NSE) market closed with 3,855 deals on Wednesday, December 9, 2020. The volume reached 283,09 million units at the close ...
The Nigerian stock market closed at 4,155 deals today, Wednesday, September 9, 2020, lower than the 4,185 deals it closed with on Tuesday, September 8...